Blog
-
—
by
Three Problems Hiding Behind Every “We Need More GPUs” Request
Why raising your cloud quota rarely fixes the bottleneck you think it fixes — and what actually does. That question came up twice in one week, in two completely unrelated fields, and both times it turned out to be the same question. One was with a computational protein design team.…
-
—
by
Unlocking New Heights in Computational Drug Discovery: How Fovus Empowered a Series B Biotech Startup to Scale Faster by 96x and Reduce Costs by 5.5x
A stealth Series B biotech startup focused on developing innovative therapies faced significant challenges in managing its cloud-based high-performance computing (HPC) workflows. The company’s computational workloads included high-throughput virtual screening (HTVS), molecular docking, molecular dynamics simulations, and AI-augmented HTVS; each requiring immense computational power. However, managing cloud infrastructure, optimizing HPC…
-
—
by
Revolutionizing Protein Structure Prediction with AI and HPC: Utilizing AlphaFold
Predicting protein structures accurately has long been a significant challenge in biological research. Proteins, essential to nearly all biological processes, derive their functions from their three-dimensional structures. Understanding these structures enables drug discovery, genetic research, and biotechnology advancements. However, determining protein structures experimentally through methods like X-ray crystallography, nuclear magnetic…
-
—
by
Transforming Computational Drug Discovery: Chemspace and Fovus
Chemspace Chemspace is a leader in the chemical compound marketplace and end-to-end computational chemistry services. Home to Enamine xREAL and Freedom Spaces – the world’s most extensive collection of commercially available chemical compounds with over 5 trillion molecules – Chemspace supports industries spanning biotechnology, life sciences, chemistry, and pharmaceuticals. By…